Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?

BACKGROUND: Intravenous thrombolytic therapy after ischaemic stroke significantly reduces mortality and morbidity. Actual thrombolysis rates are disappointingly low in many western countries. It has been suggested that higher patient volume is related to shorter door-to-needle-time (DNT) and increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherf, S., Limburg, M., Wimmers, R., Middelkoop, I., Lingsma, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839134/
https://www.ncbi.nlm.nih.gov/pubmed/27103535
http://dx.doi.org/10.1186/s12883-016-0574-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839134/
https://www.ncbi.nlm.nih.gov/pubmed/27103535
http://dx.doi.org/10.1186/s12883-016-0574-7

Ejemplares similares